# Shennon Biotechnologies Inc. — Form D

Shennon Biotechnologies Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-16. The offering totals $7.3M, of which $7.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-03-16
- Form: D
- Accession: 0001961082-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.3M
- Amount sold: $7.3M
- Investors: 9
- Date of first sale: 2022-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-476105

## Issuer

- Name: Shennon Biotechnologies Inc.
- CIK: 0001961082
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
- Phone: 000-000-0000

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| James Hardiman | Director | SOUTH SAN FRANCISCO, CA |
| LI SUN | Director | SAN FRANCISCO, CA |
| LI SUN | Executive Officer | SAN FRANCISCO, CA |

## More

- [CIK 1961082 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1961082&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001961082-23-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.